By Andrew Silver SHANGHAI (Reuters) -Drug research and development firms in China including WuXi AppTec and WuXi Biologics are changing project plans, stockpiling supplies and discussing testing ...

On June 30, WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the bioconjugate industry, ...

My name is Daniel Verheyden, vice-president of New Horizons International Culture. Our company has just signed an MOU with ...

With over 12,000 skilled employees in China, the United States, Ireland, Germany and Singapore, WuXi Biologics leverages its technologies and expertise to provide customers with efficient and ...

The Architizer A+Awards, recognized as one of the most influential global architecture awards, celebrates groundbreaking ...

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the ...

Amid escalating U.S.-China trade tensions, top Chinese drug research firms like WuXi AppTec and WuXi Biologics (HK:2269) are ...

I took a delegation of a dozen educators from Daviess County Public Schools (DCPS) in Owensboro —including sSuperintendent ...